UMC119-01 / Xuanjie - LARVOL DELTA

Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants (clinicaltrials.gov) - P1 | N=9 | Recruiting | Sponsor: Meridigen Biotech Co., Ltd. | Active, not recruiting ➔ Recruiting | Trial completion date: Jul 2025 ➔ Jul 2027 | Trial primary completion date: Dec 2022 ➔ Dec 2025

Enrollment open • Trial completion date • Trial primary completion date • Bronchopulmonary Dysplasia • Pulmonary Disease • Respiratory Diseases